Abrdn Healthcare Investors
NYSE:HQH · New York Stock Exchange
+$0.15 today
Vol 0.13M · Avg 0.14M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
9.0%
avg 4.7%
ROIC
9.0%
avg 0.5%
ROA
9.0%
avg 4.7%
Analysis
ROE is currently the strongest return metric at 9.0% versus its period average of 4.7%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Frank T. Gentile | Senior Vice President of Research and Portfolio Manager | — | — | 64 | $0.00 | <0.01% |
Daniel R. Omstead | Portfolio Manager | — | — | 73 | $178,268.56 | 0.31% |
Christopher F. Brinzey | Senior Vice President of Research and Portfolio Manager | — | — | — | $0.00 | <0.01% |
Jason C. Akus | Vice President of Research and Portfolio Manager | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -14.0% | N/A — |
| Revenue | N/A | N/A | +16.1% | N/A — |
| Net Income | N/A | N/A | -10.4% | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Recent growth has been strongest in Revenue at +16.1% over three years.
Competitors
Peer companies in the same sector
Trinity Capital Inc.
NASDAQ:TRIN
$1.25B
Virtus Investment Partners, Inc.
NASDAQ:VRTS
$945.99M
Kayne Anderson BDC, Inc.
NYSE:KBDC
$915.30M
P10, Inc.
PX
$829.75M
MidCap Financial Investment Corporation
NASDAQ:MFIC
$814.25M
Bain Capital Specialty Finance, Inc.
NYSE:BCSF
$803.72M
Carlyle Secured Lending, Inc.
NASDAQ:CGBD
$753.00M
PennantPark Floating Rate Capital Ltd.
NYSE:PFLT
$742.38M
New Mountain Finance Corporation
NASDAQ:NMFC
$675.38M
Horizon Technology Finance Corporation
NASDAQ:HRZN
$183.35M
Who manages HQH?
Abrdn Healthcare Investors (HQH) lists 4 active executives. The top listed executive is Frank T. Gentile, Senior Vice President of Research and Portfolio Manager.
Are HQH insiders buying or selling?
Recent insider activity shows net buying of $894,425.37.
Explore More
Continue the stock analysis
Jump to another research area for this company.